Ellevest, Inc. Akebia Therapeutics, Inc. Transaction History

Ellevest, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$0.32 - $0.67 $141 - $296	443 New	443 $0
Q4 2021 Jan 24, 2022	SELL	$2.26 - $3.34 $1,710 - $2,528	-757 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$2.35 - $3.88 $244 - $403	104 Added 15.93%	757 $2,000
Q2 2021 Jul 13, 2021	BUY	$2.83 - $4.2 $1,358 - $2,016	480 Added 277.46%	653 $2,000
Q4 2020 Feb 04, 2021	BUY	$2.22 - $3.78 $348 - $593	157 Added 981.25%	173 $0
Q3 2020 Oct 26, 2020	SELL	$2.39 - $13.08 $117 - $640	-49 Reduced 75.38%	16 $0
Q2 2020 Jul 06, 2020	SELL	$6.67 - $13.58 $246 - $502	-37 Reduced 36.27%	65 $1,000
Q1 2020 Apr 13, 2020	BUY	$4.1 - $10.24 $418 - $1,044	102 New	102 $1,000

120

54.9M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $438M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.